Additional Details
-
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
The Lung Research CenterChesterfield MO. 63017 -
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
University of Oklahoma Health Sciences CenterOklahoma City OK. 73104 -
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Medical University of South CarolinaCharleston SC. 29425 -
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Tufts Medical CenterBoston MA. 02111 -
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
University of Kansas Medical CenterKansas City KS. 66160 -
Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis
University of ChicagoChicago IL. 60637 -
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
Lahey Hospital and Medical CenterBurlington MA. 01805 -
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
University of South FloridaTampa FL. 33620 -
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
Duke University Health SystemDurham NC. 27710 -
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
University of California, San FranciscoSan Francisco CA. 94143 -
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
Mayo ClinicRochester MN. 55902 -
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
Cincinnati Children's Hospital Medical CenterCincinnati OH. 45229 -
Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT
Stanford UniversityStanford CA. 94305 -
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
UCLA Health Westwood Medical PlazaWestwood CA. 90095 -
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
University of Southern CaliforniaLos Angeles CA. 90033 -
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
University of South FloridaTampa FL. 33606 -
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
University of KansasKansas City KS. 66160 -
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Emory UniversityAtlanta GA. 30322 -
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
University of Texas SouthwesternDallas TX. 75235